Completed PHASE4 INTERVENTIONAL NCT00120341

Anodyne Therapy in Diabetic Sensory Neuropathy

A Randomized, Double Blind, Placebo Controlled Prospective Study to Evaluate the Effectiveness of Monochromatic Infrared Photo Energy to Improve Diabetic Sensory Neuropathy

Sponsor: Anodyne Therapy, LLC

Conditions Diabetes Mellitus Diabetic Neuropathy

Interventions Anodyne Therapy System

Updated 7 times since 2017 Last updated: May 30, 2007 Started: Apr 30, 2005 Completion: Jun 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00120341, this PHASE4 trial focuses on Diabetes Mellitus and Diabetic Neuropathy and remains completed. Sponsored by Anodyne Therapy, LLC, it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Anodyne Therapy, LLC
Scott and White Hospital & Clinic

Data source: Scott and White Hospital & Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Temple, United States